Dr. P Krause (FDA/CBER Deputy Dir., Office of Vaccine Research and Review) on #COVIDvaccine in kids: 👉Children respond to vaccine better than adults; can use lower doses 👉the lower dose will mitigate safety concerns (FDA gave EUA for Pfizer vaccine for 5-11 yo) #ACR21 https://t.co/Z7kcYQKZ8S